JP2023538859A5 - - Google Patents
Info
- Publication number
- JP2023538859A5 JP2023538859A5 JP2023509769A JP2023509769A JP2023538859A5 JP 2023538859 A5 JP2023538859 A5 JP 2023538859A5 JP 2023509769 A JP2023509769 A JP 2023509769A JP 2023509769 A JP2023509769 A JP 2023509769A JP 2023538859 A5 JP2023538859 A5 JP 2023538859A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- levodopa
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063072661P | 2020-08-31 | 2020-08-31 | |
| US63/072,661 | 2020-08-31 | ||
| PCT/US2021/048218 WO2022047298A1 (en) | 2020-08-31 | 2021-08-30 | Compositions and methods for levodopa delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538859A JP2023538859A (ja) | 2023-09-12 |
| JP2023538859A5 true JP2023538859A5 (https=) | 2024-09-05 |
Family
ID=80354133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509769A Pending JP2023538859A (ja) | 2020-08-31 | 2021-08-30 | レボドパ送達のための組成物及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230181508A1 (https=) |
| EP (1) | EP4203939A4 (https=) |
| JP (1) | JP2023538859A (https=) |
| WO (1) | WO2022047298A1 (https=) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395299B1 (en) * | 1999-02-12 | 2002-05-28 | Biostream, Inc. | Matrices for drug delivery and methods for making and using the same |
| AR044007A1 (es) * | 2003-04-11 | 2005-08-24 | Newron Pharmaceuticals Inc | Metodos para el tratamiento de la enfermedad de parkinson |
| WO2007011907A2 (en) * | 2005-07-19 | 2007-01-25 | University Of Rochester | Alpha-synuclein antibodies and methods related thereto |
| WO2010009557A1 (en) * | 2008-07-25 | 2010-01-28 | Sanomune Inc. | Tissue kallikrein for the treatment of parkinson's disease |
| PL2432454T3 (pl) * | 2009-05-19 | 2017-10-31 | Neuroderm Ltd | Kompozycje do ciągłego podawania inhibitorów dopa-dekarboksylazy |
| US20130253056A1 (en) * | 2009-05-19 | 2013-09-26 | Neuroderm, Ltd. | Continuous Administration of Levodopa and/or Dopa Decarboxylase Inhibitors and Compositions for Same |
| PT2640358T (pt) * | 2010-11-15 | 2018-02-23 | Neuroderm Ltd | Administração contínua de l-dopa, inibidores de dopa descarboxilase, inibidores de catecol-o-metil transferase e composições para os mesmos |
| TW201304822A (zh) * | 2010-11-15 | 2013-02-01 | Vectura Ltd | 組成物及用途 |
| AU2014229127B2 (en) * | 2013-03-13 | 2018-04-05 | Neuroderm Ltd | Method for treatment of parkinson's disease |
| US11278682B2 (en) * | 2014-11-09 | 2022-03-22 | Sipnose Ltd. | Device and method for aerosolized delivery of substance to a natural orifice of the body |
| BR112020013749A2 (pt) * | 2018-01-05 | 2020-12-01 | Impel Neuropharma, Inc. | dispensação intranasal de pó de levodopa por dispositivo olfativo de precisão |
| US11806326B2 (en) * | 2018-01-29 | 2023-11-07 | Jonathan Sackner-Bernstein | Methods for dopamine modulation in human neurologic diseases |
-
2021
- 2021-08-30 WO PCT/US2021/048218 patent/WO2022047298A1/en not_active Ceased
- 2021-08-30 EP EP21862913.7A patent/EP4203939A4/en active Pending
- 2021-08-30 US US18/017,767 patent/US20230181508A1/en active Pending
- 2021-08-30 JP JP2023509769A patent/JP2023538859A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009543761A (ja) | レボドパ／カルビドパの長期間２４時間腸内投与 | |
| JP3623962B2 (ja) | ヒドロキソコバラミンの鼻中投与用医薬組成物 | |
| CN105120856A (zh) | 用于改善肺功能和用于预防和/或治疗辐射诱发的肺并发症的材料和方法 | |
| EA008165B1 (ru) | Композиции для лечения простуды | |
| US9861647B2 (en) | Calcium glycerophosphate for treating and preventing respiratory diseases or conditions | |
| US9592291B2 (en) | Methods for iontophoretically treating nausea and migraine | |
| RU2019111715A (ru) | Окисляющие аммиак микроорганизмы для применения и доставки в интраназальной системе | |
| JP2023500360A5 (https=) | ||
| Pandey et al. | Efficacy of transdermal ketoprofen patch in comparison to transdermal diclofenac patch in postoperative analgesia for orthodontic extractions: a randomized split-mouth study | |
| JP2019516797A5 (https=) | ||
| JP2023538859A5 (https=) | ||
| US20090005319A1 (en) | Topical compositions for delaying ejaculation and methods of using the same | |
| KR101896441B1 (ko) | 국소투여형의 연하장애 개선용 의약품 | |
| JP2025516040A (ja) | 鼻腔内バクロフェン | |
| JP2021530568A5 (https=) | ||
| US20110288145A1 (en) | Novel Formulation For L-Tryptophane Comprising Carbidopa/Benserazide | |
| WO2023059716A8 (en) | Compositions and methods for levodopa delivery | |
| RU2318516C2 (ru) | Способ лечения эректильной дисфункции у мужчин | |
| US20210353563A1 (en) | Composition and method for treatment of respiratory disorders | |
| RU2345760C1 (ru) | Способ лечения расстройства полового влечения (либидо) у мужчин | |
| CN106507666A9 (zh) | 1，3‑丙二磺酸或其药学上可接受的盐用于治疗肉样瘤病的用途 | |
| US11819508B2 (en) | Miltefosine for the treatment of viral infections including covid-19 | |
| RU2200561C1 (ru) | Способ лечения и профилактики заболеваний | |
| RU2345778C1 (ru) | Способ лечения расстройств эрекции у мужчин | |
| RU2192255C2 (ru) | Способ лечения хронических и подострых тиреоидитов |